Filter results
Clinical Studies
Results filtered:Study status:
Open
Closed for Enrollment
Open
-
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled Study of RVT-1401 for the Treatment of Patients with Active, Moderate to Severe Graves’ Ophthalmopathy
Rochester, Minn.
The purpose of this study is to examine the effects of RVT-1401 versus placebo on proptosis responder rate at week 7, and to assess the safety and tolerability of RVT-1401 in patients with active, moderate to severe Graves' Ophthalmopathy (GO).
-
Pilot Study for the Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation
Rochester, Minn.
The purpose of this study is to evaluate the efficiency of Radiofrequency ablation (RFA) therapy to treat papillary thyroid carcinoma.
-
Pilot Study for Treatment of Amiodarone-Induced Thyroiditis with Radiofrequency Ablation
Rochester, Minn.
The purpose of this study is to analyze the changes in serum thyroid hormone levels in amiodone-induced thyroiditis (AIT) patients after radiofrequency ablation (RFA) therapy on a portion of thyroid parenchyma in order to safely decrease thyroid hormone levels into the normal range with resolution of thyrotoxicosis.
Closed for Enrollment
-
An Open Label Study to Evaluate the Safety and Efficacy of 12 Week Treatment with CFZ533 in Patients with Graves' Disease
Rochester, Minn.
The purpose of this study is to evaluate the safety and effectiveness of CFZ533 following 12 weeks of treatment in patients with Graves' disease.
-
Evaluation of New Thyroid Stimulating Immunoglobulin (TSI) Assay (MVSS Study OTP001-17 ENDO)
Rochester, Minn.
This study is being done to see if better therapies can be developed to treat Graves’ disease, using new laboratory assays
-
Pilot Study of Teriparatide for Postsurgical Hypoparathyroidism
Rochester, Minn.
Will teriparatide ( Forteo) shorten the length of hospitalization post thyroidectomy in patients with symptomatic hypoparathyroidism
-
Placental Deiodinase Activity in Thyroid Hormone Resistance
Rochester, Minn.
The purpose of this study is to determine the placental D3 activity in a woman with RTH and compare to women without RTH because we believe this may be a potential mechanism which limits fetal thyroid hormone exposure.
-
Prevention of Overt Hypothyroidism Following Radioactive Iodine Therapy for Graves' Disease
Rochester, Minn.
The study will try to answer the question of whether early treatment with levothyroxine at 4 weeks after radioactive iodine for Graves' disease will prevent overt hypothyroidism (low thyroid hormone levels).
-
Thyroid Autoimmunity Biobank
Rochester, Minn.
The purpose of this study is:
- To create a biospecimen and data resource of autoimmune thyroid disease patients and a control group of healthy volunteers for use in future research studies.Subjects will include:
- All newly diagnosed cases of autoimmune thyroid disease entities (Hashimoto’s thyroiditis, Graves’ disease, subacute thyroiditis, painless/lymphocytic/post-partum thyroiditis, Graves’ orbitopathy and Pretibial myxedema) seen at Mayo Clinic Rochester within 12-18 months of diagnosis.
- To utilize the cultured orbital fibroblasts for analyzing the role of IGF1r in GO pathophysiology and the potential role PAPP-A can play in that cascade, based on Dr. Conover’s research in the field.
- Development of improved diagnostic testing for autoimmune thyroid disease.
.